Pharma Mar, S.A. (OTCMKTS:PHMMF) Short Interest Up 116.3% in October

Pharma Mar, S.A. (OTCMKTS:PHMMF) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 26,600 shares, an increase of 116.3% from the October 15th total of 12,300 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 266.0 days.

Pharma Mar Stock Performance

PHMMF stock remained flat at $75.00 during trading on Wednesday. 50 shares of the company traded hands, compared to its average volume of 24. Pharma Mar has a 52 week low of $26.85 and a 52 week high of $75.00. The firm has a 50-day moving average of $59.44 and a 200 day moving average of $42.38. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.01.

Analyst Ratings Changes

Separately, Chardan Capital upgraded Pharma Mar to a “strong-buy” rating in a research report on Thursday, August 1st.

Pharma Mar Company Profile

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.